Gritstone Oncology, Inc. (GRTS) Social Stream
GRITSTONE BIO INC (GRTS) Price Targets From Analysts
Use the tables below to see what analysts covering GRITSTONE BIO INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 2 | $24 | $20 | $22 | $2.39 | 820.5% |
| 2022-03-14 | 3 | $20 | $15 | $17.5 | $2.39 | 632.22% |
| 2022-08-08 | 3 | $20 | $12 | $16 | $2.39 | 569.46% |
| 2022-08-22 | 4 | $20 | $2 | $11.333 | $2.39 | 374.18% |
| 2022-11-03 | 4 | $12 | $2 | $6.666 | $2.39 | 178.91% |
| 2023-03-14 | 5 | $7 | $2 | $5 | $2.39 | 109.21% |
| 2023-04-17 | 5 | $8 | $2 | $5.75 | $2.39 | 140.59% |
| 2023-08-14 | 5 | $8 | $6 | $7 | $2.39 | 192.89% |
| 2023-11-09 | 5 | $8 | $7 | $7.333 | $2.39 | 206.82% |
| 2023-12-07 | 5 | $7 | $6 | $6.666 | $2.39 | 178.91% |
The Trend in the Analyst Price Target
Over the past 34 months, GRTS's average price target has gone down $14.33.
Over the past 42 weeks, GRTS's average upside potential has been 198.78%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-14 | 4 | 7 | 2 | 5.00 | 2.67 | 87.27% |
| 2023-03-14 | 4 | 7 | 2 | 5.00 | 2.59 | 93.05% |
| 2023-04-17 | 6 | 8 | 2 | 5.75 | 2.85 | 101.75% |
| 2023-05-12 | 6 | 8 | 2 | 5.75 | 2.35 | 144.68% |
| 2023-08-10 | 6 | 8 | 2 | 5.75 | 1.82 | 215.93% |
GRTS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
GRTS's average broker recommendation rating improved by 0 over the prior 21 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- GRTS has a greater average analyst price target than 192.86% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, GRITSTONE BIO INC's upside potential (average analyst target price relative to current price) is higher than 1506.44% of them.
- In the context of all US stocks, GRITSTONE BIO INC's number of analysts covering the stock is higher than 255.35% of them.
- To contextualize these metrics, consider that out of all US stocks, GRITSTONE BIO INC's variance in analysts' estimates is lower than -893.84% of them.
Stocks similar to GRITSTONE BIO INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are STRO, AUTL, and AVRO.
View All Top Stocks by Price Target
What is the outlook for GRTS? Use POWR Ratings for clearer insight into price direction.